Hubei Goto Biopharm Co.,Ltd. (SHE:300966)

Market Cap	2.41B +24.7%
Revenue (ttm)	626.28M +14.5%
Net Income	-45.86M
EPS	-0.40
Shares Out	115.08M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,932,256
Average Volume	2,061,733
Open	20.50
Previous Close	20.70
Day's Range	20.50 - 21.10
52-Week Range	13.04 - 29.77
Beta	0.29
RSI	49.95
Earnings Date	Apr 29, 2026

About Hubei Goto Biopharm

Hubei Goto Biopharm Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of steroid drug raw materials in China and internationally. It offers starting materials, intermediates, and other pharmaceutical raw materials. The company was founded in 2006 and is based in Xiangyang, China.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2006
• Employees: 817
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300966